Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh et al
- PMID: 31097420
- DOI: 10.1136/annrheumdis-2019-215678
Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh et al
Keywords: autoantibodies; autoimmune diseases; dermatomyositis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al.Ann Rheum Dis. 2020 Aug;79(8):e97. doi: 10.1136/annrheumdis-2019-215693. Epub 2019 Jun 17. Ann Rheum Dis. 2020. PMID: 31208959 Free PMC article. No abstract available.
Comment on
-
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.Ann Rheum Dis. 2019 Jul;78(7):988-995. doi: 10.1136/annrheumdis-2018-215004. Epub 2019 Apr 24. Ann Rheum Dis. 2019. PMID: 31018961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
